Table 1

Characteristics of studies included in meta-analysis

First authorYearCohort designationPopulationFollow-up (years)Diabetes ascertainment*Baseline SUA (mg/dl)Age (years)% MenNumber of participantsNumber of casesCohort design
Medalie (15)1975IIHDSIsrael5.0Both4.8491008,688344H
Ohlson (16)1988SMBSweden13.5Both5.35010076647H
Perry (17)1995BRHSBritish12.8Report6.0501007,577194P
Chou (18)1998KSChina2.0Measure5.8505265439H
Taniguchi (19)2001OHSJapan9.5Measure5.2411006,478639P
Meisinger (20)2002MONIKAGermany
Lin (21)2004KSChina7.0Both
Chien (22)2008CSCCCChina9.0Measure5.654432,690548H
Dehghan (23)2008RSthe Netherlands10.1Both5.4over 55NA4,536462P
Nan (24)2008MNCDSMauritius8.2Both
Kramer (25)2009UCU.S.13.0Measure5.7634156655H
  • *Measure = using blood measurements, report = using reports by participants or physicians, and both = using both blood measurements and reports by participants or physicians.

  • †Number of participants included in the analysis in each study (not necessarily the number of participants at the beginning of each study). BRHS, British Regional Heart Study; CSCCC, Chin-Shan Community Cardiovascular Center; H, historical cohort; IIHDS, Israel Ischemic Heart Disease Study; JAPF, Japan Arteriosclerosis Prevention Fund; KS, The Kinmen Study; MNCDS, Mauritius Non-Communicable Diseases Surveys; MONIKA, MONIKA-Augsberg Cohort Study; NA, not available; OHS, The Osaka Health Study; P, prospective cohort; RS, The Rotterdam Study; SMB, The Study of Men Born in 1913; UC, University of California.